CAC

Certified Advisory Corp Portfolio holdings

AUM $962M
1-Year Return 12.2%
This Quarter Return
-1.29%
1 Year Return
+12.2%
3 Year Return
+46.08%
5 Year Return
10 Year Return
AUM
$169M
AUM Growth
+$29.6M
Cap. Flow
+$15.8M
Cap. Flow %
9.35%
Top 10 Hldgs %
28.48%
Holding
828
New
93
Increased
302
Reduced
96
Closed
48
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
HL icon
601
Hecla Mining
HL
$6.04B
$4K ﹤0.01%
+1,167
New +$4K
HPQ icon
602
HP
HPQ
$27.4B
$4K ﹤0.01%
236
HYS icon
603
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.44B
$4K ﹤0.01%
46
GAM
604
General American Investors Company
GAM
$1.41B
$3K ﹤0.01%
92
+1
+1% +$33
ALLE icon
605
Allegion
ALLE
$14.8B
$3K ﹤0.01%
+42
New +$3K
BPT
606
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$3K ﹤0.01%
128
+5
+4% +$117
BRX icon
607
Brixmor Property Group
BRX
$8.63B
$3K ﹤0.01%
215
+3
+1% +$42
CTRN icon
608
Citi Trends
CTRN
$313M
$3K ﹤0.01%
100
CWB icon
609
SPDR Bloomberg Convertible Securities ETF
CWB
$4.42B
$3K ﹤0.01%
+70
New +$3K
DBRG icon
610
DigitalBridge
DBRG
$2.04B
$3K ﹤0.01%
151
-4
-3% -$79
EMN icon
611
Eastman Chemical
EMN
$7.93B
$3K ﹤0.01%
28
FCX icon
612
Freeport-McMoran
FCX
$66.5B
$3K ﹤0.01%
200
+25
+14% +$375
GPN icon
613
Global Payments
GPN
$21.3B
$3K ﹤0.01%
34
HEDJ icon
614
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.79B
$3K ﹤0.01%
102
HYI
615
Western Asset High Yield Opportunity Fund Inc.
HYI
$273M
$3K ﹤0.01%
237
INCY icon
616
Incyte
INCY
$16.9B
$3K ﹤0.01%
40
IPGP icon
617
IPG Photonics
IPGP
$3.56B
$3K ﹤0.01%
15
IVZ icon
618
Invesco
IVZ
$9.81B
$3K ﹤0.01%
111
NBIX icon
619
Neurocrine Biosciences
NBIX
$14.3B
$3K ﹤0.01%
48
PAA icon
620
Plains All American Pipeline
PAA
$12.1B
$3K ﹤0.01%
148
+2
+1% +$41
PCY icon
621
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.24B
$3K ﹤0.01%
+124
New +$3K
PEG icon
622
Public Service Enterprise Group
PEG
$40.5B
$3K ﹤0.01%
70
PSEC icon
623
Prospect Capital
PSEC
$1.34B
$3K ﹤0.01%
600
-445
-43% -$2.23K
QGEN icon
624
Qiagen
QGEN
$10.3B
$3K ﹤0.01%
91
REGN icon
625
Regeneron Pharmaceuticals
REGN
$60.8B
$3K ﹤0.01%
10